New drug duo aims to fight cancer without harsh chemo
Disease control
Terminated
This study tested a combination of two immunotherapy drugs, pembrolizumab and rituximab, for adults with marginal zone lymphoma who needed treatment. The goal was to see if this chemotherapy-free approach could control the cancer as well as standard treatments that include chemot…
Phase: PHASE2 • Sponsor: University of Ulm • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC